Literature DB >> 12920038

Induction of human gamma globin gene expression by histone deacetylase inhibitors.

Hua Cao1, George Stamatoyannopoulos, Manfred Jung.   

Abstract

We investigated the induction of human gamma globin gene activity by 3 classes of histone deacetylase inhibitors: amide analogues of trichostatin A, hydroxamic acid analogues of trapoxin, and scriptaid and its analogues. The screening consisted of measuring the effects of these compounds on gamma and beta human gene promoter activity by using cultures of GM979 cells stably transfected with a construct containing a gamma promoter linked to firefly luciferase and a beta promoter linked to renilla luciferase. Compounds belonging to all 3 classes induced gamma gene promoter activity in the screening assay in low micromolar concentrations. Histone deacetylase (HDAC) inhibitors increased acetylation of histone H4 and induced the expression of endogenous murine embryonic genes. They also increased the levels of gamma mRNA and the frequency of fetal hemoglobin-containing erythroblasts in erythroid burst-forming unit (BFUe) cultures from healthy adult individuals. Compounds that displayed very similar degrees of inhibition of the HDAC activity in an HDAC enzymatic assay differed strikingly on their effects on gamma gene promoter activity, raising the possibility of selectivity of HDACs that interact with the gamma globin gene chromatin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920038      PMCID: PMC2808412          DOI: 10.1182/blood-2003-02-0478

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  51 in total

1.  A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library.

Authors:  G H Su; T A Sohn; B Ryu; S E Kern
Journal:  Cancer Res       Date:  2000-06-15       Impact factor: 12.701

2.  Novel in vitro assay for the detection of pharmacologic inducers of fetal hemoglobin.

Authors:  E Skarpidi; G Vassilopoulos; Q Li; G Stamatoyannopoulos
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

3.  Oral isobutyramide therapy in patients with thalassemia intermedia: results of a phase II open study.

Authors:  M Domenica Cappellini; G Graziadei; L Ciceri; A Comino; P Bianchi; A Porcella; G Fiorelli
Journal:  Blood Cells Mol Dis       Date:  2000-02       Impact factor: 3.039

4.  Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation.

Authors:  M Jung; G Brosch; D Kölle; H Scherf; C Gerhäuser; P Loidl
Journal:  J Med Chem       Date:  1999-11-04       Impact factor: 7.446

5.  Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells.

Authors:  K Schmidt; R Gust; M Jung
Journal:  Arch Pharm (Weinheim)       Date:  1999-10       Impact factor: 3.751

6.  Oral isobutyramide reduces transfusion requirements in some patients with homozygous beta-thalassemia.

Authors:  S Reich; C Bührer; G Henze; D Ohlendorf; M Mesche; P Sinha; A Kage; C Müller; B Vetter; A E Kulozik
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Context-dependent EKLF responsiveness defines the developmental specificity of the human epsilon-globin gene in erythroid cells of YAC transgenic mice.

Authors:  K Tanimoto; Q Liu; F Grosveld; J Bungert; J D Engel
Journal:  Genes Dev       Date:  2000-11-01       Impact factor: 11.361

8.  Murine erythroleukemia cell line GM979 contains factors that can activate silent chromosomal human gamma-globin genes.

Authors:  G Zitnik; P Hines; G Stamatoyannopoulos; T Papayannopoulou
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

9.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

10.  Oral sodium phenylbutyrate therapy in homozygous beta thalassemia: a clinical trial.

Authors:  A F Collins; H A Pearson; P Giardina; K T McDonagh; S W Brusilow; G J Dover
Journal:  Blood       Date:  1995-01-01       Impact factor: 22.113

View more
  27 in total

1.  Histone deacetylase 9 activates gamma-globin gene expression in primary erythroid cells.

Authors:  Shalini A Muralidhar; Valya Ramakrishnan; Inderdeep S Kalra; Wei Li; Betty S Pace
Journal:  J Biol Chem       Date:  2010-11-13       Impact factor: 5.157

2.  Systematic RNAi studies on the role of Sp/KLF factors in globin gene expression and erythroid differentiation.

Authors:  Jie Hong Hu; Patrick Navas; Hua Cao; George Stamatoyannopoulos; Chao-Zhong Song
Journal:  J Mol Biol       Date:  2006-12-22       Impact factor: 5.469

3.  Regulation of γ-globin gene expression involves signaling through the p38 MAPK/CREB1 pathway.

Authors:  Valya Ramakrishnan; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2011-04-15       Impact factor: 3.039

4.  Fetal globin induction--can it cure beta thalassemia?

Authors:  Susan P Perrine
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

5.  Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea.

Authors:  Maureen M Okam; Erica B Esrick; Elyse Mandell; Federico Campigotto; Donna S Neuberg; Benjamin L Ebert
Journal:  Blood       Date:  2015-06-04       Impact factor: 22.113

6.  The switch from fetal to adult hemoglobin.

Authors:  Vijay G Sankaran; Stuart H Orkin
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 7.  Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders.

Authors:  Daniel E Bauer; Sophia C Kamran; Stuart H Orkin
Journal:  Blood       Date:  2012-08-17       Impact factor: 22.113

8.  Reactivation of developmentally silenced globin genes by forced chromatin looping.

Authors:  Wulan Deng; Jeremy W Rupon; Ivan Krivega; Laura Breda; Irene Motta; Kristen S Jahn; Andreas Reik; Philip D Gregory; Stefano Rivella; Ann Dean; Gerd A Blobel
Journal:  Cell       Date:  2014-08-14       Impact factor: 41.582

Review 9.  Fetal haemoglobin induction in sickle cell disease.

Authors:  Alireza Paikari; Vivien A Sheehan
Journal:  Br J Haematol       Date:  2017-11-16       Impact factor: 6.998

Review 10.  Hemoglobin genetics: recent contributions of GWAS and gene editing.

Authors:  Elenoe C Smith; Stuart H Orkin
Journal:  Hum Mol Genet       Date:  2016-06-23       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.